ArticleComputational intelligence and neuroscience2022
Personalized Liver Cancer Risk Prediction Using Big Data Analytics Techniques with Image Processing Segmentation.
Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
- Retracted: Personalized Liver Cancer Risk Prediction Using Big Data Analytics Techniques with Image Processing Segmentation.Computational intelligence and neuroscience · 2024Article
- Development and validation of a risk prediction model for incident liver cancer.Frontiers in public health · 2022Article
Corrections and comments
- Retracted
Authors and funding
6 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A technology known as data analytics is a massively parallel processing approach that may be used to forecast a wide range of illnesses. Many scientific research methodologies have the problem of requiring a significant amount of time and processing effort, which has a negative impact on the overall performance of the system. Virtual screening (VS) is a drug discovery approach that makes use of big data techniques and is based on the concept of virtual screening. This approach is utilised for the development of novel drugs, and it is a time-consuming procedure that includes the docking of ligands in several databases in order to build the protein receptor. The proposed work is divided into two modules: image processing-based cancer segmentation and analysis using extracted features using big data analytics, and cancer segmentation and analysis using extracted features using image processing. This statistical approach is critical in the development of new drugs for the treatment of liver cancer. Machine learning methods were utilised in the prediction of liver cancer, including the MapReduce and Mahout algorithms, which were used to prefilter the set of ligand filaments before they were used in the prediction of liver cancer. This work proposes the SMRF algorithm, an improved scalable random forest algorithm built on the MapReduce foundation. Using a computer cluster or cloud computing environment, this new method categorises massive datasets. With SMRF, small amounts of data are processed and optimised over a large number of computers, allowing for the highest possible throughput. When compared to the standard random forest method, the testing findings reveal that the SMRF algorithm exhibits the same level of accuracy deterioration but exhibits superior overall performance. The accuracy range of 80 percent using the performance metrics analysis is included in the actual formulation of the medicine that is utilised for liver cancer prediction in this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.